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b Department of Otolaryngology Head & Neck Surgery, Hainan Branch of PLA General Hospital, Sanya, 572000, ChinaAbstractObjective: To investigate surgical indications, operative techniques, complications and auditory and speech rehabilitation for cochlear implant
(CI) in children with otitis media with effusion (OME).
Material and methods: This is a retrospective review of records of 24children with bilateral profound sensorineural hearing loss and OME who
were implanted during January 2011 to November 2014 in the Department of Otorhinolaryngology and Head and Neck Surgery at the PLA
Hospital, using one-stage implantation via the facial recess approach and round window insertion. The incus was removed in 8 cases during the
implantation procedure. Local infiltration of dexamethasone and adrenaline in the middle ear was also performed. Postoperative complications
were examined. Preoperative and postoperative questionnaires including Categories of Auditory Performance (CAP), Speech Intelligibility
Rating (SIR), and the Meaningful Auditory Integration Scale (MAIS) were collected.
Results: All electrodes were implanted successfully without any immediate or delayed complications. Inflammatory changes of middle ear
mucosa with effusion were noted in all implanted ears. The scores of post-implant CAP and SIR increased significantly in all 24 cases
(t ¼ 25.95 and 14.09, respectively for CAP and SIR, p < 0.05).
Conclusions: One-stage CI via the facial recess approach with round window insertion is safe and effective in cochlear implant candidates with
OME, as seen in the 24 children in our study who achieved improved auditory performance and speech intelligibility after CI.
Copyright © 2015, PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cochlear implant (CI) is one of the most significant treat-
ments to help restore auditory function in patients with severe
to profound sensorineural hearing loss. It has become a rela-
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for cochlea implant is chronic middle ear inflammation due to
concerns of increased risk of intracranial infection and/or
device extrusion (Olgun et al., 2005; Achiques et al., 2010).
Recently there is mounting new evidence indicating that
cochlear implants can be safely performed in patients with
chronic otitis media or atelectasis (Chen et al., 2009; Sampaio
et al., 2011; Migirov et al., 2006). Otitis media with effusion
(OME), also called serous otitis media, is a very common
childhood disease. The reported incidence is as high as 20%
among children, with a peak around ages one to two years
(Migirov et al., 2006; Moriniere et al., 1998; American
Academy of Family Physicians et al., 2004). Cochlear im-
plants in pediatric patients, especially those younger than 2gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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are often confronted with OME in the expanding population of
cochlear implant candidates. Accordingly, this study aims to
report our experiences with cochlear implantation in children
with OME.
2. Material and methods
A retrospective review of 24children (ages 11 months to 5.2
years)who underwent cochlear implantation in an ear with
active OMEwas conducted between January 2011 to November
2014 in the Department of Otorhinolaryngology and Head and
Neck Surgery, PLA Hospital, China. Study protocol was
approved by the hospital's Institutional ReviewBoard. All the 24
subjects were under 6 years of age without any residual hearing
when admitted to our department as cochlear implant candi-
dates. The candidates received a comprehensive preoperative
radiological evaluation. Their radiologic findings showed mid-
dle ear andmastoid opacification with intact ossicles, indicating
the presence of OME. Otoscopy found no evidence of tympanic
membrane perforation. After audiological assessment, the 24
candidates were all diagnosed with bilateral profound sensori-
neural hearing loss without any residue hearing. All the opera-
tions were performed by the same experienced surgical team in
our department. The demographic data, etiology of deafness,
and surgical techniqueswere retrieved frommedical records and
summarized in Table 1.
Based on how the incus was handled, the subjects were
divided into Group1 (incus left in place, n ¼ 16) and Group 2
(incus removed, n ¼ 8).Table 1
Demographic and clinical details of the 24 children.
Case Gender Age at implantation Cause of deaf
1 Male 1 year 7 months CHL
2 Female 2 years 8 months LVAS
3 Female 2 years 8 months LVAS
4 Male 2 years 4 months CHL
5 Male 1 year 9 months CHL
6 Male 3 years 5 months CHL
7 Male 1 year 7 months CHL
8 Male 1 year 5 months LVAS
9 Male 1 year 3 months CHL
10 Female 2 years 6 months LVAS&MM
11 Female 2 years 5 months CHL
12 Female 2 years 1 months MM
13 Male 4 years 5 months CHL
14 Female 11 months CHL
15 Female 2 years 7 months LVAS
16 Male 1 year 4 months CHL
17 Male 1 year 7 months LVAS
18 Male 1 year 8 months CHL
19 Female 3 years 10 months CHL
20 Male 4 years 10 months LVAS
21 Male 2 years 7 months CHL
22 Female 5 years 2 months LVAS
23 Male 1 year 7 months MM
24 Female 2 years 1 months CHL
CHL: Congenital Hearing Loss; LVAS: Large Vestibular Aqueduct Syndrome; M
Group2: Facial Recess Approach Implantation with Incus Removal.At follow ups, complications, and auditory and speech
rehabilitation outcomes were reviewed. Complications
included wound infection, meningitis or other intracranial
infections, cerebrospinal fluid otorrhea, post-implant perfora-
tion of tympanic membrane, device extrusion and recurrence
of OME. To assess post-implant auditory function and speech
recognition, a prospective questionnaire was constructed
including questions from Categories of Auditory Performance
(CAP) (Archbold et al., 1998), Speech Intelligibility Rating
(SIR) (Allen et al., 2001) and the Meaningful Auditory Inte-
gration Scale (MAIS or infant toddler-MAIS) (Robbins et al.,
1991). The composite questionnaires were administered
through interviews with the parents by an audiologist. All the
subjects reported daily use of the CI and attending speech
therapy programs.
3. Surgical techniques
Based on preoperative imaging and intraoperative finding,
all subjects were determined to have active OME in the
implant ear at the time of CI operation. To pursue an early
hearing and speech rehabilitation, all the children in our
study received one-stage cochlear implant operations (one
patient had an adenoidectomy procedure done 3 months
before CI).
All cochlear implantations in this study were performed via
the facial recess approach with round window insertion under
general anesthesia. Following a retroauricular incision,
approximately 3 cm in length, an intact canal wall mastoid-

























M: Mondini Malformation; Group1: Facial Recess Approach Implantation;
Table 2
CI characteristics and auditory speech performance scores of the 24 children.
Case Age at follow-up Length of deafness (month) Length of CI use (month) CAP SIR MAISa
Pre Post Pre Post
Group1: Facial Recess Approach Implantation
1 5 years 5 months 19 44 0 7 1 5 37
2 5 years 9 months 32 35 1 6 1 4 35
3 5 years 6 months 32 33 1 6 1 4 34
4 5 years 2 months 28 33 0 6 1 4 34
5 4 years 7 months 21 33 0 5 1 4 33
6 6 years 3 months 41 33 0 5 1 4 37
7 4 years 4 months 19 22 0 5 1 3 33
8 3 years 1 months 17 19 0 4 1 3 30
9 3 years 9 months 15 29 0 5 1 3 33
10 4 years 11 months 30 28 0 5 1 4 35
11 4 years 9 months 29 27 0 5 1 4 35
12 4 years 2 months 25 24 0 5 1 3 30
13 6 years 5 months 53 23 1 5 1 3 37
14 2 years 7 months 11 19 0 4 1 4 30
15 4 years 1 months 31 17 1 5 1 3 31
16 2 years 2 months 16 9 0 3 1 2 28
Group2: Facial Recess Approach Implantation with Incus Removal
17 4 years 2 months 19 30 1 5 1 4 34
18 4 years 2 months 20 29 0 5 1 4 33
19 6 years 2 months 46 27 0 6 1 4 36
20 7 years 2 months 24 25 2 6 5 38
21 4 years 11 months 31 26 0 5 1 4 36
22 7 years 4 months 20 25 4 7 5 38
23 3 years 6 months 19 22 0 5 1 3 33
24 3 years 10 months 25 20 0 5 1 3 32
a Use the IT-MAIS questionnaire if the subject is under 3-year old.
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ization of the short process of the incus. The facial recess was
identified and enlarged to approach the round window niche.
Intraoperatively, edematous mucosa with effusion was noticed
in the middle ear, confirming active serous otitis media. The
middle ear and mastoid cavity were drained and irrigated with
dexamethasone (1 mL of 5 mg/mL dexamethasone in normal
saline solution, Shandong Xinhua Pharmaceutical Company
Limited) and epinephrine (0.3 mL of 1 mg/mL, 1:10,000,
Beijing YOKON).
For casesin Group 2, the incudostapedial joint was sepa-
rated and the incus removed, followed by expansion of the
mastoid antrum by drilling the posterior bony buttress be-
tween the facial recess and fossa incudis for insertion of the
electrode array in a straight line through the round window
membrane.
In all cases, an anchoring well was drilled in the cranium
for placement of the internal receiver-stimulator. The overhang
of round window niche was removed using a diamond burr
(0.5e1 mm) form maximum exposure of the round window
membrane. Cochleostomy was finished anteroinferiorly from
the round window membrane into the basal turn of the co-
chlea. The electrode array was inserted carefully into the scala
tympani following the curvature of the cochlea and the
cochleostomy was sealed by small pieces of temporalis fascia.
The retroauricular incision was closed in layered sutures.
Absorbable sutures and mastoid dressing was applied in all
cases.4. Statistical analysis
Statistical analysis was performed with the SPSS16.0
software. Pre- and post-implant CAP and SIR scores were
compared with self-paired T-test, following usual conditions
of application. Significance was set at P < 0.05.
5. Results
After the receiver-stimulator was placed, intraoperative
neural response telemetry (NRT) responded well in all 24
children, which confirmed appropriate placement of the elec-
trode array in the cochlea. Five days after implantation, an X-
ray in Stenvers projection was performed in all cases, which
also confirmed appropriate positions of the electrode array.
The average follow up was 27 months, ranging from 10
months to 3 years 9 months, during which time none of the
subjects experienced any immediate or delayed complications.
No recurrence of OME was detected in both groups after the
CI surgery.
The questionnaire surveys, composed of questions from
CAP, SIR and MAIS (or IT-MAIS) are shown in Table 2.
Table 3 lists the age at implantation, age at follow up,
length of deafness, length of CI use, pre-and post-implant
auditory and speech performance scores.
The preoperative and postoperative CAP scores were
0.46 ± 0.93 and 5.21 ± 0.88, respectively. The preoperative
and postoperative SIR scores were 1.17 ± 0.57 and
Table 3
Mean, standard deviation (S.D.) and median of characteristics of CI use and
pre- and post-implant scores of MAIS or IT-MAIS, CAP and SIR.
Items Mean ± S.D. Median
Age at Implantation (month) 29.12 ± 13.79 26.50
Age at Follow-up (month) 57.08 ± 16.02 56.00
Length of Deafness (month) 25.96 ± 10.07 24.50
Length of CI Use (month) 26.75 ± 7.22 27.00
MAIS or IT-MAISa 33.88 ± 2.79 38.00
CAP
Pre-implant 0.46 ± 0.93 0.00
Post-implant 5.21 ± 0.88 5.00
SIR
Pre-implant 1.17 ± 0.57 1.00
Post-implant 3.71 ± 0.75 4.00
a Use the IT-MAIS questionnaire if the subject is under 3-year old.
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Groups1 and 2, postoperative scores were higher than preop-
erative scores (t ¼ 25.95 and 14.09, respectively, p < 0.01)
(Fig. 1). Given the difference in the number of cases between
Group 1 and Group 2, scores of MAIS or IT-MAIS, CAP and
SIR were not compared between the two groups.
6. Discussion
Middle ear infection can spread via a cochlear implant
electrode into the labyrinth and even intracranial space to
cause post-operative infection, meningitis or fatal intracranial
complications (Melton and Backous, 2011; Vincenti et al.,
2014; Luntz et al., 2004; Bara~nano et al., 2010; Sun et al.,
2014). The presence of chronic and recurrent inflammation
in mastoid and middle ear cavities is considered a risk factor
for cochlear implant electrode impairment and/or extrusion
(Luntz et al., 2004; Bara~nano et al., 2010). Additionally,
effusion and bleeding from inflamed middle ear mucosa can
obscure the operative field and challenge even the most
experienced surgeons intraoperatively (Vincenti et al., 2014;
Luntz et al., 2004; Bara~nano et al., 2010; Sun et al., 2014;
Wong et al., 2014). Based on these considerations, the cur-
rent recommendation for cochlear implant candidates is to
treat chronic otitis media with effusion before CI surgery.Fig. 1. The comparison between preimplant and postimplant of the mean
scores for CAP and SIR.The standard treatment of OME includes use of intranasal
corticosteroids for a limited time and myringotomy with or
without insertion of ventilating tubes (Olgun et al., 2005;
American Academy of Family Physicians et al., 2004).
Treatment of underlying eustachian tube dysfunction,
including adenoidectomy and tonsillectomy, are often required
in persistent or recurrent cases (American Academy of Family
Physicians et al., 2004; Xenellis et al., 2008). With improve-
ment of surgical techniques, one stage cochlear implantation
has become feasible in patients with OME, albeit with a higher
rate of complications (Chen et al., 2009).
With the goal to improve surgical techniques and to
reduce complications for CI patients with active OME, we
developed a new technique that involved incus removal after
opening the facial recess, via the classical posterior tympa-
notomy and facial recess approach. We hypothesized that
removing incus would contribute to enlargement of tympanic
volume, thus improving ventilation of the middle ear.
Migirov et al. (2006) reported that performing mastoidec-
tomy during cochlear implantation had no influence on nat-
ural history of otitis media with effusion. The reason may be
that aeration and gas composition of the middle ear depend to
a great extent on the function of mastoid and middle ear
mucosa (Sade et al., 1995). With incus removal in conjunc-
tion with mastoidectomy, the volume of tympanic cavity will
be enlarged further without excessive impairment of middle
ear mucosa.
During postoperative follow-up in our study, all electrodes
were activated successfully without any immediate or delayed
complications. Furthermore, all the implanted devices func-
tioned normally and all 24 children achieved improved audi-
tory performance and speech intelligibility.
7. Conclusions
In our study, one-stage operation via the facial recess
approach with round window insertion proved to be safe and
effective in cochlear implant candidates with active OME. No
immediate or delayed complications were encountered in our
patients with or without incus removal. Postoperative follow-
up findings showed improvement of auditory function and
speech intelligibility in all 24 children. Based on this study, we
propose incus removal in cochlear implant candidates with
OME via the classic facial recess approach with round window
insertion to avoid staged procedures and gain early rehabili-
tation of audition and speech.
Acknowledgments
We thank all the patients and their families for their
participation and cooperation in this study. This work was
supported by grants from the National Basic Research Pro-
gram of China (973 Program) (#2012CB967900;
2011CBA01000), the National Natural Science Foundation of
China (NSFC #81271082) and we acknowledged the grants of
the National Key Basic Research Program of China (973
Program), No. 2014CB943003.
129Q.-Q. Hao et al. / Journal of Otology 10 (2015) 125e129References
Achiques, M.T., Morant, A., Munoz, N., et al., 2010. Cochlear implant
complications and failures. Acta Otorrinolaringol. Esp. 61 (6),
412e417.
Allen, C., Nikolopoulos, T.P., Dyar, D., et al., 2001. Reliability of a rating
scale form measuring speech intelligibility after pediatric cochlear im-
plantation. Otol. Neurotol. 22 (5), 631e633.
American Academy of Family Physicians, American Academy of
Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics
Subcommittee on Otitis Media With Effusion, 2004. Otitis media with
effusion. Pediatrics 113 (5), 1412e1429.
Archbold, S., Lutman, M.E., Nikolopoulos, T.P., 1998. Categories of auditory
performance: inter-user reliability. Br. J. Audiol. 32 (1), 7e12.
Bara~nano, C.F., Sweitzer, R.S., Mahalak, M.L., et al., 2010. The management
of myringotomy tubes in pediatric cochlear implant recipients. Arch.
Otolaryngol. Head. Neck Surg. 136, 557e560.
Chen, Z., Yu, D., Wu, Y., et al., 2009. Indications and common surgical ap-
proaches for cochlear implantation in China. ORL J. Otorhinolaryngol. Rel
Spec. 71 (4), 187e191.
Luntz, M., Teszler, C.B., Shpak, T., 2004. Cochlear implantation in children
with otitismedia: second stage of a long-term prospective study. Int. J.
Pediatr. Otorhinolaryngol. 68, 273e280.
Melton, M.F., Backous, D.D., 2011. Preventing complications in pediatric
cochlear implantation. Curr. Opin. Otolaryngol. Head. Neck Surg. 19,
358e362.Migirov, L., Amir, A., Kronenberg, J., 2006. The influence of mastoidectomy
on natural history of secretory otitis media in cochlear implant children.
ORL J. Otorhinolaryngol. Rel Spec. 68 (3), 156e158.
Moriniere, S., Soin, C., Lescanne, E., et al., 1998. Epidemiology of otitis
media with effusion. Rev. Prat. 8, 838e842.
Olgun, L., Batman, C., Gultekin, G., et al., 2005. Cochlear implantation in
chronic otitis media. J. Laryngol. Otol. 119 (12), 946e949.
Robbins, A.M., Renshaw, J.J., Berry, S.W., 1991. Evaluating meaningful
auditory integration in profoundly hearing-impaired children. Am. J. Otol.
12 (Suppl), 144e150.
Sade, J., Luntz, M., Levy, D., 1995. Middle ear gas composition and middle
ear aeration. Ann. Otol. Rhinol. Laryngol. 104, 369e373.
Sampaio, A.L., Araujo, M.F., Oliveira, C.A., 2011. New criteria of indication
and selection of patients to cochlear implant. Int. J. Otolaryngol. 573968.
Sun, J.Q., Sun, J.W., Hou, X.Y., 2014. Cochlear implantation with round
window insertionin children with otitis media with effusion. ORL J.
Otorhinolaryngol. Rel Spec. 76 (1), 13e18.
Vincenti, V., Pasanisi, E., Bacciu, A., et al., 2014. Cochlear implantation in
chronic otitis media and previous middle ear surgery:20 years of experi-
ence. Acta Otorhinolaryngol. Ital. 34 (4), 272e277.
Wong, M.C., Shipp, D.B., Nedzelski, J.M., et al., 2014. Cochlear implantation
in patients with chronic suppurative otitis media. Otol. Neurotol. 35 (5),
810e814.
Xenellis, J., Nikolopoulos, T.P., Marangoudakis, P., et al., 2008. Cochlear
implantation in atelectasis and chronic otitis media: long-term follow-up.
Otol. Neurotol. 29 (4), 499e501.
